Search clinical trials for: 0.25% human albumin solution (Placebo)

Total 6287 results

Hainan People's Hospital
Southern Medical University, China

Unknown

Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient

Sepsis

China
Aerie Pharmaceuticals

Completed

Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure

Glaucoma

United States
Aldeyra Therapeutics, Inc.

Completed

A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Jordi Carratala
Institut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos III

Unknown

Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia. (ALBUCAP)

Hypoalbuminemia | Community-acquired Pneumonia

Spain
Ruijin Hospital

Completed

Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery

Gastric Cancer | Anastomotic Leak
University of Pecs

Unknown

The Effect of Albumin Supplementation on the Inflammatory and Oxidative Stress Markers in Septic Patients

Sepsis | Albumin Supplementation | Albumin Therapy

Hungary
Universiti Kebangsaan Malaysia Medical Centre

Recruiting

Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes

Pancreatic Cancer | Anastomotic Leak | Pancreatic Fistula | Pancreaticoduodenectomy | Delayed Gastric Emptying

Malaysia
The First Hospital of Jilin University

Completed

Phase Ib of Recombinant Human Albumin Injection

Ascites

China
Shanghai East Hospital

Completed

Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study） (PRIME-HFrEF)

Heart Failure, Systolic

China
University of Alberta

Withdrawn

A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS

Postural Orthostatic Tachycardia Syndrome
Centre Hospitalier Universitaire de Besancon
Ministry of Health, France

Terminated

Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial Peritonitis (ALB-CIRINF)

Sepsis | Renal Failure | Cirrhosis

France
Georgetown University
Baxter Healthcare Corporation

Terminated

Albumin for Intracerebral Hemorrhage Intervention (ACHIEVE)

Intracerebral Hemorrhage

United States
Egymedicalpedia

Recruiting

Effect of Early Administration of Albumin 20% Versus Crystalloid

Septic Shock

Egypt
Baylor College of Medicine
National Institute of Neurological Disorders and Stroke (NINDS)

Terminated

Treatment of Subarachnoid Hemorrhage With Human Albumin

Subarachnoid Hemorrhage

United States, Canada
AbbVie (prior sponsor, Abbott)

Completed

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Diabetic Nephropathy | Chronic Kidney Disease

United States, Puerto Rico
Imperial College London

Terminated

Study of Albumin to Reduce Inflammation Following Surgery

Systemic Inflammatory Response Syndrome | Cardiopulmonary Bypass

United Kingdom
Fundació Institut de Recerca de l'Hospital de la...
Spanish Clinical Research Network - SCReN

Unknown

Influence of Albumin on Acute Renal Dysfunction Associated With Cardiac Surgery Under Extracorporeal Circulation

Acute Kidney Injury

Spain
Tarsus Pharmaceuticals, Inc.

Completed

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-1)

Blepharitis

United States
University Hospital, Angers

Unknown

High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury

Severe Head Injury

France
Dermavant Sciences GmbH

Completed

A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
University of Manitoba

Recruiting

Spinal Anesthesia For Enhanced Recovery After Liver Surgery (SAFER-L)

Pain, Postoperative | Liver Neoplasms | Hepatectomy

Canada
Sichuan Haisco Pharmaceutical Group Co., Ltd
Second Affiliated Hospital, School of Medicine, Zhejiang University

Completed

Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy Volunteers

Healthy Volunteers

China
University of Saskatchewan

Withdrawn

Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%

Coronary Artery Disease | Aortic Valve Disease | Mitral Valve Disease

Canada
Protgen Ltd

Completed

Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

Hepatic Ascites

China
University Hospital, Linkoeping

Completed

Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects ((RAV))

Edema Secondary

Sweden
Hospital de Clinicas de Porto Alegre

Unknown

Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot Study (ALTERNATE)

Renal Impairment | All Cause Mortality

Brazil
Aldeyra Therapeutics, Inc.

Completed

The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease

Dry Eye

United States
Instituto Grifols, S.A.

Completed

Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"

Liver Failure | Liver Cirrhosis

Spain
Aleksander Krag
EASL - CLIF Consortium

Recruiting

Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Decompensated Cirrhosis and Ascites

Spain, Denmark, United Kingdom, Hungary, Germany, Belgium, Netherlands
Aldeyra Therapeutics, Inc.

Completed

A Clinical Trial to Assess Subjects With Dry Eye Disease.

Dry Eye

United States
Aldeyra Therapeutics, Inc.

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease

Dry Eye Syndromes

Canada
Fresenius Kabi

Completed

Voluven® in Paediatric Patients

Cardiac Surgery | Cardiopulmonary Bypass

Austria, Belgium
Yale University

Recruiting

Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures

Coronary Artery Bypass Graft Surgery | Aortic Valve Replacement

United States
Pfizer

Completed

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Encephalitis, Tick-Borne

Austria, Germany, Poland
Seoul National University Hospital

Not yet recruiting

Initial Resuscitation With Albumin in Hemorrhagic Shock to Reduce Positive Fluid Balance (ABSOLUTE)

Bleeding | Massive Hemorrhage | Massive Transfusion Protocol
Yale University

Withdrawn

The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome

Ovarian Hyperstimulation Syndrome

United States
Govind Ballabh Pant Hospital

Suspended

Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis

Cirrhosis | Ascites

India
Cara Therapeutics, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KARE)

Pruritus | Atopic Dermatitis

United States, Canada
Aldeyra Therapeutics, Inc.

Completed

The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease

Dry Eye

United States
Aldeyra Therapeutics, Inc.

Completed

The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease

Dry Eye | Dry Eye Syndromes

United States
Aldeyra Therapeutics, Inc.

Completed

The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.

Allergic Conjunctivitis

Canada
Aldeyra Therapeutics, Inc.

Completed

A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease

Dry Eye Disease

Canada
Aldeyra Therapeutics, Inc.

Completed

The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis

Allergic Conjunctivitis

Canada
Aldeyra Therapeutics, Inc.

Completed

A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease

Dry Eye

United States
Aldeyra Therapeutics, Inc.

Completed

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Dry Eye Syndrome

United States
CSL Behring

Withdrawn

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Diffuse Cutaneous Systemic Sclerosis

Belgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland
University Hospital, Toulouse

Completed

Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2) (MESAMI2)

Chronic Myocardial Ischemia

France
Coretherapix
Hospital General Universitario Gregorio Marañon; Universitaire Ziekenhuizen... and other collaborators

Completed

Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI (CAREMI)

Acute Myocardial Infarction

Spain
Universitas Sebelas Maret

Completed

Evaluating the Efficacy of Channa Striata in Stabilizing eNOS in Patients With Septic.

Sepsis

Indonesia
William C. Oliver

Terminated

Lactated Ringer's Versus 5% Human Albumin: Cardiac Surgical Patients

Hemodynamic Stability

United States

3

Subscribe